The effect of obecabtagene autoleucel (obe-cel) on adult patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) and extramedullary disease (EMD).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, University College London, Moffitt Cancer Center, Manchester Royal Infirmary, Methodist Healthcare, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Hospital Universitari i Politècnic La Fe, King's College Hospital NHS Foundation Trust, University of California, San Francisco, University of California, Davis, University of Chicago, Dana-Farber Cancer Institute, Autolus (United Kingdom), RWE (Germany), The University of Texas MD Anderson Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162548640
Cites:
Cited by:
Related to: